← Back to Clinical Trials
Recruiting NCT06028165

NCT06028165 CABG Based on CT-FFR Versus Conventional Coronary Angiography

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06028165
Status Recruiting
Phase
Sponsor Myongji Hospital
Condition Coronary Artery Disease
Study Type INTERVENTIONAL
Enrollment 96 participants
Start Date 2023-10-20
Primary Completion 2024-10-01

Trial Parameters

Condition Coronary Artery Disease
Sponsor Myongji Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 96
Sex ALL
Min Age 40 Years
Max Age 80 Years
Start Date 2023-10-20
Completion 2024-10-01
Interventions
Coronary artery bypass grafting based on conventional coronary angiographyCoronary artery bypass grafting based on cardiac computed tomography-derived fractional flow reserve.

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The aims of study are (1) to compare early and 1-year graft patency rates in patients who underwent coronary artery bypass grafting (CABG) based on conventional coronary angiography(CAG) versus cardiac computed tomography(CT)-derived fractional flow reserve(FFR), and (2) to demonstrate difference in clinical outcomes between the 2 groups.

Eligibility Criteria

Inclusion Criteria: * age equal or more than 40 * age equal or less than 80 * patients who undergo coronary artery bypass grafting due to multi-vessel coronary artery disease * patients who agree to the enrollment Exclusion Criteria: * Patients with heart failure (left ventricular ejection fraction \< 25%) * patients who have intractable ventricular arrhythmia * patients who has been treated for cancer * patients who has infectious disease * patients who are planned to undergo combined cardiac surgery * patients who has medical co-morbidity with expected survival less than 1 year * patients with a history of previous cardiac surgery * Patients with chronic renal failure requiring dialysis * patients who undergo emergency operation

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology